Workflow
权益变动
icon
Search documents
三联锻造: 简式权益变动报告书(安徽同华高新技术中心(有限合伙))
Zheng Quan Zhi Xing· 2025-07-14 16:25
Group 1 - The report details the equity change of Wuhu Sanlian Forging Co., Ltd., indicating a reduction in shares held by Anhui Tonghua High-tech Center (Limited Partnership) through centralized bidding [1][2] - The report confirms that the equity change is in compliance with the relevant laws and regulations, ensuring no false records or misleading statements are present [2][5] - The purpose of the equity change is based on the operational development needs of the information disclosing party [5] Group 2 - As of the report date, Anhui Tonghua holds 22,218,640 shares, representing 10.0000% of the total share capital after the reduction [4][7] - The reduction involved a total of 285,280 shares, with 90,200 shares sold before the annual equity distribution and 195,080 shares sold after [7][8] - The report outlines that there are no restrictions on the rights of the shares held by the information disclosing party, such as pledges or freezes [8]
水晶光电: 简式权益变动报告书(星星集团)
Zheng Quan Zhi Xing· 2025-07-14 14:07
浙江水晶光电科技股份有限公司 简式权益变动报告书 浙江水晶光电科技股份有限公司 简式权益变动报告书 上市公司名称:浙江水晶光电科技股份有限公司 上市地点:深圳证券交易所 股票简称:水晶光电 股票代码:002273 信息披露义务人名称:星星集团有限公司 住所:浙江省台州市椒江区洪西路1号 通讯地址:浙江省台州市椒江区洪家星星电子产业基地总部大楼 权益变动性质:持股比例减少 签署日期:二〇二五年七月十四日 浙江水晶光电科技股份有限公司 简式权益变动报告书 信息披露义务人声明 一、 本报告书依据《中华人民共和国证券法》、 《上市公司收购管理办法》、 《公开发行证券的公司信息披露内容与格式准则第15号—权益变动报告书》等法 律、法规和规范性文件编写。 二、 本信息披露义务人签署本报告书已获得必要的授权和批准。 三、 依据《中华人民共和国证券法》、《上市公司收购管理办法》的规定, 本报告书已全面披露信息披露义务人在浙江水晶光电科技股份有限公司(以下简 称"水晶光电")拥有权益的股份变动情况。截至本报告书签署之日,除本报告 书披露的信息外,信息披露义务人没有通过任何其他方式增加或减少其在浙江水 晶光电科技股份有限公司中拥 ...
长龄液压: 长城证券股份有限公司关于江苏长龄液压股份有限公司详式权益变动报告书之财务顾问核查意见
Zheng Quan Zhi Xing· 2025-07-14 09:21
Core Viewpoint - The financial advisor, Changcheng Securities, has conducted a thorough review of the detailed equity change report for Jiangsu Changling Hydraulic Co., Ltd, confirming that the disclosed information is true, accurate, and complete, and complies with relevant laws and regulations [1][5][24]. Summary by Relevant Sections Financial Advisor's Review - The financial advisor guarantees that all documents and statements provided are truthful and complete, with no false records or misleading statements [1][5]. - The advisor has verified the content of the detailed equity change report and found no substantial discrepancies with the disclosed information [1][5]. Equity Change Details - The equity change involves the acquisition of 43,211,714 shares of Jiangsu Changling Hydraulic, representing 29.99% of the total shares, by Wuxi Core Technology Partnership and Jiangyin Chenglian Investment Partnership [4][26]. - Following the equity change, Wuxi Core Technology will hold 36,007,360 shares (24.99% of total shares), while Jiangyin Chenglian will hold 7,204,354 shares (5.00% of total shares) [26]. Purpose of Equity Change - The purpose of the equity change is to support the future development of the listed company by leveraging operational management experience and industry resources [24][25]. - The financial advisor considers the stated purpose of the equity change to be reasonable and compliant with existing laws and regulations [24]. Future Plans - Wuxi Core Technology plans to further acquire an additional 12.00% of shares within the next 12 months through a partial tender offer [24][25]. - The advisor confirms that the equity change will not aim to terminate the listing status of Jiangsu Changling Hydraulic [25]. Compliance and Governance - The financial advisor has provided necessary guidance on compliance with securities market regulations to the responsible parties involved in the equity change [23][24]. - The advisor believes that the parties involved possess the capability to manage the listed company in accordance with modern corporate governance standards [23][24].
润泽科技:控股股东及其一致行动人权益变动1.97%
news flash· 2025-07-11 13:44
Core Points - The controlling shareholder of Runze Technology, Jingjin Jirunze, and its concerted party, Beijing Tianxinghui, have reduced their shareholding due to unfulfilled performance commitments, resulting in a total decrease of 1.97% in the company's shares [1] - Specifically, Jingjin Jirunze decreased its holdings by 85.3174 million shares, while Beijing Tianxinghui reduced its holdings by 370,400 shares, totaling a reduction of 85.6878 million shares [1] - Following this repurchase and cancellation, the total share capital of the company decreased from 1.721 billion shares to 1.634 billion shares [1]
万里股份: 万里股份详式权益变动报告书
Zheng Quan Zhi Xing· 2025-07-11 10:12
Core Viewpoint - The report details the equity change of Chongqing Wanli New Energy Co., Ltd., indicating that the information discloser, Zheng Hairuo, has increased his shareholding to 36,913,101 shares, representing 24.08% of the total share capital as of July 9, 2025 [3][21]. Summary by Sections Section 1: Definitions - The report defines key terms such as "information discloser," "control accounts," and "equity change," clarifying the context of the report [4]. Section 2: Information Discloser Introduction - Zheng Hairuo is identified as the information discloser, with personal details including his nationality, address, and lack of foreign residency rights [15][17]. Section 3: Purpose and Decision-Making Process of Equity Change - The equity change is based on Zheng Hairuo's confidence in the company's future development and long-term investment value [20]. Section 4: Method of Equity Change - The equity change was executed through centralized bidding on the secondary market, resulting in a net increase of 36,913,101 shares, which is over 5% of the company's total shares [21]. Section 5: Source of Funds - The total funds involved in this equity change amount to approximately 785.58 million yuan, sourced entirely from Zheng Hairuo's personal funds [24]. Section 6: Future Plans Post-Equity Change - There are no plans to change the company's main business or make significant adjustments in the next 12 months, and no major asset disposals or acquisitions are planned [25][26]. Section 7: Impact of Equity Change on Company Independence - The company will maintain its operational independence, with Zheng Hairuo and his control accounts ensuring separation in assets, personnel, and business operations [27]. Section 8: Major Transactions with the Company - No significant transactions have occurred between Zheng Hairuo and the company in the past 24 months, aside from disclosed related transactions [31].
奥特维: 无锡奥特维科技股份有限公司简式权益变动报告书
Zheng Quan Zhi Xing· 2025-07-10 16:21
Core Viewpoint - The report details the equity changes of Wuxi Autowei Technology Co., Ltd., indicating a reduction in shareholding by key stakeholders due to personal funding needs, while maintaining control over the company [1][3][5]. Group 1: Equity Change Details - The equity change involves a total reduction of 15,750,000 shares, representing a decrease from 51.00% to 46.01% of the total share capital [3][4]. - Specific reductions include: - Ge Zhiyong: 7,500,000 shares (from 27.03% to 24.65%) - Li Wen: 6,310,000 shares (from 17.70% to 15.70%) - Wuxi Aochuang Investment Partnership: 1,298,000 shares (from 4.20% to 3.79%) - Wuxi Aoli Investment Partnership: 642,000 shares (from 2.07% to 1.87%) [3][4][5]. Group 2: Stakeholder Information - The report identifies four key stakeholders: Ge Zhiyong, Li Wen, Wuxi Aochuang Investment Partnership, and Wuxi Aoli Investment Partnership, all of whom are in a concerted action relationship [2][3]. - Ge Zhiyong and Li Wen are both Chinese nationals, with no foreign residency rights [2][3]. Group 3: Future Plans - The stakeholders do not rule out the possibility of further increasing or decreasing their holdings in the next 12 months, adhering to relevant legal disclosure obligations [3][5]. - There are no current plans or agreements for additional share acquisitions within the next year [5]. Group 4: Regulatory Compliance - The report confirms compliance with the Securities Law and relevant regulations, ensuring that all necessary disclosures regarding the equity changes have been made [1][3].
长龄液压: 江苏长龄液压股份有限公司详式权益变动报告书
Zheng Quan Zhi Xing· 2025-07-10 13:20
Core Viewpoint - The report details the equity changes of Jiangsu Changling Hydraulic Co., Ltd, highlighting the acquisition of 29.99% of its shares by Wuxi Hexin Tingtao Technology Partnership and Jiangyin Chenglian Shuangying Investment Partnership, aiming to gain control over the company [1][2][23]. Group 1: Equity Change Details - The equity change involves the acquisition of 43,211,714 shares, representing 29.99% of the total share capital of Jiangsu Changling Hydraulic [5][23]. - The acquisition is structured through agreements signed on July 10, 2025, between the acquirers and existing shareholders [21][23]. - Following the acquisition, Wuxi Hexin Tingtao will hold 36,007,360 shares (24.99%), while Jiangyin Chenglian Shuangying will hold 7,204,354 shares (5.00%) [23][24]. Group 2: Parties Involved - The information disclosing parties include Wuxi Hexin Tingtao Technology Partnership and Jiangyin Chenglian Shuangying Investment Partnership, both limited partnerships [1][6]. - The actual controller of these partnerships is Hu Kangqiao, who is also the executive partner [10][18]. - Jiangyin Chenglian Shuangying is controlled by the Jiangyin High-tech Zone State-owned Assets Supervision and Administration Office [10][18]. Group 3: Future Plans - The acquirers plan to further increase their stake by an additional 12% through a partial tender offer, aiming for greater control over Jiangsu Changling Hydraulic [21][22]. - The tender offer will involve acquiring 17,290,448 shares, with commitments from existing shareholders to accept the offer [21][22]. - The report emphasizes that the acquisition does not intend to terminate the listing status of Jiangsu Changling Hydraulic [21].
亚钾国际: 详式权益变动报告书(汇能集团)(修订稿)
Zheng Quan Zhi Xing· 2025-07-10 11:12
Core Viewpoint - The report details the equity changes of Yaqi International Investment (Guangzhou) Co., Ltd., highlighting the increase in shareholding by Huineng Holding Group Co., Ltd. and the implications for corporate governance and control [1][2][3]. Group 1: Equity Changes - Huineng Group acquired 46,202,560 shares, representing 5% of the total share capital, making it the largest shareholder of Yaqi International [5]. - The report indicates that the actual controller of Huineng Group is Guo Jinshu, who holds 28.99% of the shares directly, while another entity, Ordos Huayuan Jiaxin Trading Co., Ltd., holds 29.53% of the shares [6][8]. Group 2: Corporate Governance - The information disclosure obligor will maintain active communication with other shareholders to optimize corporate governance and may adjust the board composition to strengthen its control over the listed company [2][3]. - The report emphasizes compliance with relevant laws and regulations in any future strategic decisions regarding the company [2][3]. Group 3: Financial Overview - Huineng Group's main business includes coal mining and mineral resource exploration, with significant financial data reported for the years 2021, 2022, and 2023 [19].
人福医药: 招商证券关于人福医药详式权益变动报告书之财务顾问核查意见
Zheng Quan Zhi Xing· 2025-07-10 10:11
Core Viewpoint - The financial advisor, China Merchants Securities Co., Ltd., has verified the detailed equity change report of Renfu Pharmaceutical Group Co., Ltd., confirming that the disclosed content and format comply with regulations and that there are no false records, misleading statements, or significant omissions [1][6][9]. Summary by Sections Financial Advisor's Verification - The financial advisor conducted a thorough review of the detailed equity change report and confirmed that the information provided by the disclosing party is true, accurate, complete, and timely, with no significant omissions or misleading statements [2][6]. - The advisor's opinion is based on the assumption that the disclosing party has fully and timely fulfilled its obligations related to the transaction [2][3]. Disclosing Party's Information - The disclosing party, China Merchants Life Science (Wuhan) Co., Ltd., has a registered capital of 200 million RMB and is involved in medical research and development [7][12]. - The equity structure of the disclosing party shows that it is wholly owned by China Merchants Innovation Technology (Group) Co., Ltd. [12][15]. Equity Change Details - Following the signing of the agreement, the disclosing party and its affiliates will collectively hold 429,276,816 shares of the listed company, accounting for 26.30% of the total share capital [5][9]. - The trust plan "Chun Ni 1" was established to execute the restructuring plan of the company "Wuhan Contemporary Technology Industry Group Co., Ltd." and involves the transfer of 11.70% of Renfu Pharmaceutical's shares [9][10]. Financial Performance of Related Entities - Wuhan High-Tech State-owned Holding Group Co., Ltd. reported total assets of 994.47 billion RMB, total liabilities of 707.50 billion RMB, and a net profit of 1.54 billion RMB for the year 2024 [23][24]. - The financial data for China Merchants Group shows total assets of 28,751.03 billion RMB and a net profit of 786.16 million RMB for the year 2024 [25].
人福医药: 人福医药详式权益变动报告书
Zheng Quan Zhi Xing· 2025-07-10 10:11
Core Viewpoint - The report outlines the equity changes of Renfu Pharmaceutical Group Co., Ltd., detailing the involvement of various stakeholders and the establishment of a concerted action relationship between the parties involved to stabilize the company's management and promote its development [24][25]. Group 1: Equity Change Overview - The equity change involves the concerted action relationship established between招商生命科技 (Wuhan) Co., Ltd. and 武汉高科国有控股集团有限公司, allowing them to collectively hold 429,276,816 shares of Renfu Pharmaceutical, representing 26.30% of the total share capital [27][29]. - Prior to this change, the combined holdings of the involved parties were 403,089,608 shares, accounting for 24.70% of the total share capital [26][28]. Group 2: Stakeholder Information - 招商生命科技 holds 114,255,773 shares directly, equating to a 7.00% stake, while the other parties include 生科投资发展 with 97,933,558 shares (6.00%), 春泥 1号 with 190,900,277 shares (11.70%), and 武汉高科 with 26,187,208 shares (1.60%) [28]. - The report confirms that the stakeholders have not changed their respective shareholding percentages as a result of this equity change [27]. Group 3: Purpose and Future Plans - The primary purpose of this equity change is to stabilize the management of Renfu Pharmaceutical and enhance its governance structure, thereby improving asset quality and ensuring healthy development [25]. - 招商生科 plans to increase its holdings in Renfu Pharmaceutical by at least 1% and no more than 2% within six months following the announcement of the increase plan, with a maximum purchase price set at 25.53 RMB per share [25][26].